CordLife
| singapore
Singapore / English
cordlife
Select Country:

Cordlife Group Limited1, formerly known as “Cordlife Pte Ltd” is a leading service provider of stem cell banking from cord blood (Singapore and Hong Kong) and the umbilical cord (Hong Kong). The Company owns and operates two stem cell banks with full processing and cryopreservation storage facilities in Singapore and Hong Kong. The Company also has a strategic investment in the only cord blood bank operating in Guangzhou, China. The first cord blood bank to be set up in Singapore and among the first in Asia, Cordlife Group Limited’s in-depth knowledge of cord blood banking practices is widely recognised by numerous quality gold standards such as the AABB, the International Organisation for Standardisation (ISO) and in-country regulators.

Cordlife Limited is a stem cell banking company listed on the Australian Securities Exchange. A winner of Technology Pioneer award conferred by the World Economic Forum, the Group owns and operates three state-of-the-art stem cell processing and cryopreservation facilities in India, Indonesia and the Philippines.

1Cordlife Group Limited and Cordlife Limited are two separate companies. The companies are however affiliated through contractual agreements for the fulfillment of cross-border customer requests. The Cordlife brand and www.cordlife.com are properties of Cordlife Group Limited.

Cordlife Group Limited is Singapore's first private cord blood bank, operating since 2001. A leading service provider of stem cell banking in Singapore, Hong Kong and China with a network extending into India, Philippines and Indonesia, Cordlife Singapore is the first cord blood bank in Southeast Asia to be accredited by AABB, an international body that recognises the highest standards in cord blood banking. Cordlife Group Limited is also Singapore's only private cord blood bank with a successful transplant and application track record. Cordlife Group Limited stores stem cells only in FDA approved, multi-compartmented cryobags - providing the safest storage method - endorsed worldwide. Cordlife Group Limited, its subsidiary CordLife (Hong Kong) Limited and its associate, CordLife Medical Philippines, Inc., are the first in Singapore, Hong Kong and Philippines to use Sepax® fully automated cord blood processing technology to optimise stem cell recovery. The Cordlife Quality Guarantee, the only such guarantee in Singapore, Hong Kong and its associates, namely: CordLife Medical Philippines, Inc., PT. CordLife Indonesia and CordLife Sciences India Pvt Ltd assures your baby of a cord blood unit replacement or a compensation of US$25,000 if the cord blood unit loses its viability at point of transplant.